Block Grant R43CA134036

This Project Grant award of $246,124.00 from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) supports the development of the BREATHS system at Vanderbilt University Medical Center (VUMC). BREATHS is a personalized, patient-centered technology that aims to help breast cancer patients undergoing radiation therapy consistently execute deep inspiration breath hold (DIBH) techniques. The BREATHS system includes video display glasses and a...

The National Science Foundation awarded Malcova Inc. $1,000,000 under the Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a novel non-planar spectral breast computed tomography device. Malcova will use the one-year project grant term from May 1, 2023 to April 30, 2024 to further the device's design, build a working prototype, and conduct validation testing using anthropomorphic phantoms. The non-invasive breast CT device employs a new scanning method and...

This $175,000 National Science Foundation project grant supports the development of multi-modal soft tissue characterization technologies for non-invasive breast imaging at the University of Massachusetts Dartmouth from April 2022 through March 2024. Funded under the NSF's Computer and Information Science and Engineering program (CFDA 47.070), the research aims to establish optimization algorithms and parameters for visualizing breast tissue cross-sections non-invasively using an integrated...

Federal Project Grant Award Summary Biotex, Inc. received a Direct to Phase II Small Business Innovation Research (SBIR) award of $1.3M from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) on September 18, 2025, for development and commercialization of the OncoMagnetic (OMTX) device. The company is delivering a novel, non-invasive wearable technology that generates spinning oscillating magnetic fields (SOMFs) to treat brain cancers, particularly...

Federal Grant Award Summary Imagine Scientific Inc. received a $779,658 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) effective September 1, 2025, through August 31, 2027. The company is developing and commercializing STARLIGHT, a monochromatic X-ray imaging system designed to transform mammography screening and early breast cancer detection. This innovative technology provides selectable monochromatic X-ray...

This $255,730 National Science Foundation project grant supports the development of self-assembling molecular brachytherapy for treatment of metastatic cancer. The goal is to enable radiation therapies for metastatic cancer, which accounts for approximately 90% of cancer deaths in the United States each year. The grantee, Oncurie, LLC, seeks to advance a radiotherapy approach that exploits cancer cells themselves as catalysts for therapeutic delivery. Specifically, the company will develop an...

Radiabeam Technologies, LLC received a $199,722 Project Grant award from the Department of Energy Office of Science on February 22, 2021 to develop a compact radiofrequency chopper for high-energy heavy-ion beams. The Office of Science Financial Assistance Program (CFDA 81.049) aims to deliver scientific discoveries and tools to transform understanding of nature and advance U.S. energy and economic security. Under this award, Radiabeam Technologies will design and test a compact RF chopper to...

Federal Grant Award Summary Award Details: The National Cancer Institute (NCI) awarded Embiosys Inc. a $2.76 million Project Grant under the Cancer Treatment Research program (CFDA 93.395) on September 17, 2025, with completion targeted for August 31, 2027. The research is being conducted at the company's facility in North Andover, Massachusetts. Product/Service Delivered: Embiosys is developing an innovative wearable induced electric field (IEF) therapy device—a washable, non-ionizing...

Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering awarded The Washington University a project grant of $598,134 (awarded August 5, 2025; completion date July 31, 2029) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). This funding supports the development of sensing collimator technology to advance Single Photon Emission Computed Tomography (SPECT) imaging capabilities for...

Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $1.554 million Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop trackerless surgical navigation technology for minimally invasive liver surgery. The award, effective August 1, 2025 through July 31, 2029, supports the development of novel computer vision and...